Clinical Trials

100 enrolled

EndocrineOther

Motor Activity, Obesity, Multiple Endocrine Neoplasia Type 1

NCT06448208 2026-03-09

Defining Response Criteria for PET Scans for People With Neuroendocrine Tumors

11 enrolled

Neuroendocrine Tumors

NCT07446036 2026-03-03

Prediction Model for Postoperative Headache After Transsphenoidal Pituitary Surgery

500 enrolled

Headache, Pituitary Neoplasms

NCT03946527 2026-03-02

LAMPARA

10 enrolled

Paraganglioma, Pheochromocytoma

NCT04321954 2026-02-27

Lenvatinib in Locally Advanced Invasive Thyroid Cancer

Differentiated Thyroid Cancer

NCT04969887 2026-02-27

MOST-CIRCUIT

240 enrolled

Genital Neoplasms, Female, Neuroendocrine Tumors

NCT03416686 2026-02-25

METATHYRAF

14 enrolled

Differentiated Thyroid Cancer

NCT04675710 2026-02-19

Pembrolizumab, Dabrafenib, and Trametinib Before Surgery for the Treatment of BRAF-Mutated Anaplastic Thyroid Cancer

Thyroid Carcinoma, Anaplastic

NCT04993261 2026-02-19

An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors

71 enrolled

Carcinoid Tumor, Serotonin Syndrome

NCT02143726 2026-02-11

Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer

35 enrolled 14 charts

Phase 1 Active not recruiting

Thyroid cancer, Hurthle cell

NCT04459273 2026-02-05

FAPI PET RDRC

26 enrolled

CNSDermatologicEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckNETOther hematologic neoplasm

Adrenal Gland Neoplasms, Urinary Bladder Neoplasms, Brain Neoplasms, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Carcinoma, Hepatocellular, Neoplasms, Unknown Primary, Skin Neoplasms, Testicular Neoplasms, Thymus Neoplasms, Thyroid Neoplasms, Cholangiocarcinoma, Neuroendocrine Tumors, Hematologic Neoplasms

NCT03333616 2026-01-21

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

100 enrolled

EndocrineGenitourinary

Penile Neoplasms, Urogenital Neoplasms, Adrenocortical Carcinoma, Carcinoma, Small Cell

NCT03891784 2026-01-14

Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors

EndocrineGastrointestinalNET

20 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Adenoma, Islet Cell

NCT06232564 2026-01-14

PELICAN

20 enrolled

Neuroendocrine Tumors

NCT05735912 2026-01-13

ERASIN-RCT

60 enrolled

Insulinoma

NCT03181100 2026-01-09

Atezolizumab With Chemotherapy in Treating Patients With Anaplastic or Poorly Differentiated Thyroid Cancer

50 enrolled

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT03950609 2026-01-09

Lenvatinib and Everolimus in Treating Patients With Advanced, Unresectable Carcinoid Tumors

36 enrolled

Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

NCT06936813 2026-01-08

The PROMISE Survey

530 enrolled

Phase 1 Active not recruiting

Pituitary Neoplasms, Prolactinoma

NCT03465618 2026-01-07

A First in Human Study Using 89Zr-cRGDY Ultrasmall Silica Particle Tracers for Malignant Brain Tumors

17 enrolled

Brain Neoplasms, Pituitary Neoplasms

NCT05470595 2025-12-30

LCNEC-ALPINE

67 enrolled

EndocrineThoracic

Lung Neoplasms, Carcinoma, Neuroendocrine

NCT04813042 2025-12-24

WOD

293 enrolled

Psychological Well-Being, Multiple Endocrine Neoplasia Type 1

NCT03728361 2025-12-18

Nivolumab and Temozolomide in Treating Patients With Recurrent or Refractory Small-Cell Lung Cancer or Advanced Neuroendocrine Cancer

55 enrolled

EndocrineNETThoracic

Lung Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT05064150 2025-12-18

NET-PRO

EndocrineGastrointestinalNET

2,539 enrolled

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT04701307 2025-12-15

Niraparib and Dostarlimab for the Treatment of Small Cell Lung Cancer and Other High-Grade Neuroendocrine Carcinomas

48 enrolled

EndocrineThoracic

Lung Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

NCT02743741 2025-12-03

Lu-DOTATATE Treatment in Patients With 68Ga-DOTATATE Somatostatin Receptor Positive Neuroendocrine Tumors

195 enrolled

Neuroendocrine Tumors

NCT03541720 2025-12-03

18F-Fluorodopamine PET Studies of Neuroblastoma and Pheochromocytoma

13 enrolled

Phase 2/3 Active not recruiting

Neuroblastoma, Pheochromocytoma

NCT06100367 2025-12-02

11C-Metomidate PET/CT for Endocrine Hypertension and Characterisation of Adrenal Tumours

100 enrolled

Adrenal Gland Neoplasms, Hyperaldosteronism, Neoplasm Metastasis

NCT04624477 2025-11-28

Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer

450 enrolled

Papillary Thyroid Microcarcinoma, Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT03271892 2025-11-26

AS-PTC

200 enrolled

Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT04412629 2025-11-24

Cabozantinib in High Grade Neuroendocrine Neoplasms

35 enrolled

Phase 1/2 Active not recruiting

High Grade Neuroendocrine Neoplasms

NCT04530916 2025-11-17

WB2020

58 enrolled

Cardiovascular Diseases, Hypertension, Multiple Endocrine Neoplasia Type 1, Atherosclerosis

NCT05255159 2025-11-17

Lesion-to-lesion Comparison of 68Ga-HA-DOTATATE, 18F-DOPA, and 18F-FDG PET/CT in the Evaluation of Metastatic Neuroendocrine Tumors

50 enrolled

Neuroendocrine Tumors

NCT04759911 2025-11-13

Selpercatinib Before Surgery for the Treatment of RET-Altered Thyroid Cancer

Thyroid Cancer, Papillary, Thyroid Neoplasms, Carcinoma, Medullary, Thyroid Carcinoma, Anaplastic

NCT01709292 2025-10-27

Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer

24 enrolled

Thyroid Cancer, Papillary, Thyroid Neoplasms

NCT03048279 2025-10-27

Registry for Multiple Endocrine Neoplasia Syndromes: MEN1/MEN2

1,500 enrolled

Multiple Endocrine Neoplasia

NCT04544111 2025-10-07

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

19 enrolled

Thyroid cancer, Hurthle cell, Thyroid cancer, follicular, Thyroid Cancer, Papillary, Thyroid Neoplasms, Adenoma, Oxyphilic, Adenocarcinoma, Follicular

NCT03457948 2025-09-03

Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases

32 enrolled

Neuroendocrine Tumors

NCT06648967 2025-08-21

Impact of Different Carbohydrate Feedings on a Hydrogen Breath Curve and Self-reported Gastrointestinal Complaints

5 enrolled

Malabsorption Syndromes, Multiple Endocrine Neoplasia Type 1

NCT04042753 2025-08-08

Nivolumab and Ipilimumab in People With Aggressive Pituitary Tumors

9 enrolled

Phase 1 Active not recruiting

Pituitary Diseases, Pituitary Neoplasms

NCT05262556 2025-08-07

NP-101 (TQ Formula) With Nivolumab and Ipilimumab in Advanced or Metastatic Extra-pulmonary Neuroendocrine Carcinomas

15 enrolled

EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor, Carcinoma, Neuroendocrine

NCT05927623 2025-07-20

MisterFIt

60 enrolled

Muscular Atrophy, Osteoporosis, Multiple Endocrine Neoplasia Type 1, Osteoporotic Fractures

NCT03335670 2025-07-14

Gallium 68 Pentixafor in Patients With Neuroendocrine Tumors

Neuroendocrine Tumors

NCT04560127 2025-07-10

Camrelizumab in Combination With Apatinib in Patients With Radioactive Iodine-refractory Differentiated Thyroid Cancer

20 enrolled

Radioactive Iodine-refractory Differentiated Thyroid Cancer

NCT03085056 2025-07-03

Trametinib in Combination With Paclitaxel in the Treatment of Anaplastic Thyroid Cancer

13 enrolled

Thyroid Carcinoma, Anaplastic

NCT04238624 2025-07-02

Study of Cemiplimab Combined With Dabrafenib and Trametinib in People With Anaplastic Thyroid Cancer

16 enrolled

Thyroid Neoplasms, Thyroid Carcinoma, Anaplastic

NCT05233878 2025-06-30

PRONO-PARAG

25 enrolled

Paraganglioma

NCT05768776 2025-06-25

MOSES

200 enrolled

EndocrineGenitourinary

Prostatic Hyperplasia, Multiple Endocrine Neoplasia Type 1

NCT03583528 2025-06-13

DOTATOC PET/CT for Imaging NET Patients

CNSDermatologicEndocrineNETThoracic

800 enrolled

Carcinoid Tumor, Vipoma, Ganglioneuroma, Glucagonoma, Insulinoma, Medulloblastoma, Meningioma, Neuroblastoma, Paraganglioma, Pheochromocytoma, Pituitary Neoplasms, Carcinoma, Merkel Cell, Gastrinoma, Carcinoma, Medullary, Neuroendocrine Tumors, Small Cell Lung Carcinoma

NCT03674723 2025-05-30

Metabolic Availability of Methionine From Mung Beans in Healthy Adults

6 enrolled